Update: WHO Warns Ebola Is Rebounding in Congo as Nigeria's Case Raises New Fears

Kenya holds the line, for now

Kenya remains the outbreak's best-behaved front. The WHO report confirms nine confirmed cases, including one death, with all eight secondary infections linked to the original imported case and detected among people already under quarantine. Kenya reported its first case on October 6: a man who had arrived from the DRC. Every case since has come from inside the quarantine net, which means, so far, the virus has found nobody outside it.

That is the difference between a contained cluster and a runaway chain. Kenya's authorities have traced more than 99 percent of contacts, and the first cohort of contacts completes its 21-day quarantine on October 25. If nobody breaks quarantine, Kenya's chapter of this outbreak could close with single digits. If someone does, the math changes fast.

The Nigeria case: why the gap between symptoms and confirmation scares experts

Nigeria confirmed its first case on Tuesday, October 20, and this week brought fresh details that make the picture more complicated. The patient is a woman, described in Nigerian media as the wife of a diplomat, who returned to Abuja on October 3 after staying in Uganda since September 16. She traveled aboard an Ethiopian Airlines flight transiting through Addis Ababa, according to information presented at an emergency meeting of the Nigeria Centre for Disease Control and Prevention. She developed symptoms on October 7, was seen at a private Abuja hospital on October 11, and was only lab-confirmed on October 20. Forty-four contacts have been identified and are being traced.

That 13-day gap between symptom onset and confirmation is what worried the WHO. The agency warned that the prolonged interval raised concerns about "potentially undetected exposures and secondary transmission." In plain terms: anyone she met, touched, or sat near during those two weeks is now part of the tracing race, and the clock started late.

There was also a significant correction to the story. Ugandan authorities had earlier suggested the woman had traveled to eastern DRC for business. Africa CDC director-general Jean Kaseya told the AFP news agency on Thursday that she was originally from Uganda but lived in Abuja, and clarified that she had not traveled to the DRC at all. The source of her infection is still under investigation, and Uganda's health ministry has stressed that "travel through Uganda does not establish that infection occurred here." Uganda has no confirmed active cases.

Nigeria matters beyond its own borders. It is the fourth African country affected in this outbreak, and the first case in West Africa. The 2014 West Africa outbreak, which killed more than 11,000 people, is still a living memory, and Nigeria's success in containing that one is why health officials watch Abuja so closely. The NCDC has activated its incident management system, and the WHO is supporting case investigation, contact tracing, and infection control.

A wider African response is taking shape

The ripple effects are already visible. Ghana's health ministry said it had not recorded any Ebola cases but was strengthening surveillance and preparedness at its points of entry, citing the risk from frequent travel between Ghana, Kenya, and Nigeria. The ministry pointed to direct flights between Kenya and Ghana and heavy Ghana-Nigeria traffic as reasons to tighten airport screening. Ghana is not the first country to move: Tanzania earlier introduced mandatory health declarations and 21-day monitoring for high-risk travelers, Kenya has border screening running at Busia, and the United States has barred travelers from the DRC from boarding US-bound commercial flights within 21 days of departure.

This is the pattern of a multi-country outbreak response: one imported case in a new country triggers screening and surveillance in its neighbors, which is exactly how you keep an imported case from becoming an imported chain.

Where the DRC outbreak itself stands

Strip away the international headlines and the engine of this outbreak is still the DRC, where the numbers are once again moving the wrong way. The health zones affected now number in the dozens, eight provinces are involved, and North Kivu has overtaken Ituri as the worst-hit province, a shift that matters because North Kivu's crowded cities and mobile population make contact tracing much harder.

A few things to keep in mind from the last few weeks. About a third of recent new cases have been community deaths, people who died at home rather than in treatment centers, which means some chains of transmission are still invisible to responders. Children have been hit hard, with school cases in Ituri and MSF reporting that very young children account for an outsized share of cases in North Kivu. On the response side, nearly 9,000 frontline workers have received the Ervebo vaccine under research protocols, though it was designed for the Zaire strain, not Bundibugyo, and the TUMAINI trial testing a vaccine candidate against this strain is still expected to start before the end of October. There is no approved vaccine or specific treatment for the Bundibugyo strain, the one behind this outbreak.

The funding picture remains stark. Africa CDC has disclosed that donors have disbursed roughly $962 million, yet organizations on the ground acknowledge receiving far less, and the DRC's health minister has publicly warned aid groups to disclose what they actually got. Money announced is not money spent, and the gap shows up in hospital beds, contact-tracing teams, and fuel for response vehicles.

What it means for India, and for Mumbai

No cases have been detected in India, and nothing in this week's developments changes that. The health ministry's travel advisory for Ebola remains in force, with airport health organizations screening arriving passengers, the Air Suvidha portal process for incoming travelers, and a 21-day watch guidance for anyone returning from affected regions. If you or someone you know is traveling to or from Central, East, or West Africa, the rules are the same as they have been: monitor your health for 21 days after leaving an affected area, and report fever, headache, muscle pain, vomiting, or unexplained bleeding to a doctor or health authority immediately.

One thing worth repeating, because it comes up every time a traveler panics: Ebola is not diagnosed with a routine blood test. Ebola PCR testing in India is done only at designated national reference laboratories, such as the National Institute of Virology in Pune, and only for people with a genuine exposure history. A commercial diagnostic lab does not test for Ebola, and you should not walk into one asking for it.

For everyday fevers, especially after travel, the sensible first steps are the ordinary ones: a fever profile, malaria antigen, and a complete blood count, because malaria, dengue, and typhoid are far likelier causes of a post-travel fever in India than Ebola ever will be. The difference is the exposure story. Fever plus recent travel to the DRC, Kenya, or Nigeria with contact with a sick person is a call-your-health-authority situation, not a book-a-test situation. Everything else starts with the routine tests your doctor would order anyway.

For Mumbai, the practical angle is air travel. Mumbai's international airport handles heavy traffic from Africa and the Gulf, and the advisory system is designed exactly for situations like this. There is no reason to change any health behavior, and no Ebola testing is needed for the general public.

What to watch next

This outbreak now has three separate scoreboards, and each bears watching. In the DRC, the question is whether the third weekly increase becomes a sustained trend or the curve bends back down; the next official case counts will tell. In Kenya, the watch is for any case outside the quarantine net, and for the first quarantine cohort completing its 21-day cycle on October 25. In Nigeria, everything hinges on the 44 contacts: any positive test among them would turn an imported case into a local chain. Beyond that, the watch list is the same as before: the TUMAINI vaccine trial, any imported case in a new country, and any change in the WHO's risk assessment or the PHEIC status declared back in May.

The original post in this series and the Nigeria update remain the backstory; this week's WHO report is the new chapter, and it is not the one responders were hoping for.

References

• WHO Regional Office for Africa, Ebola outbreak situation report (published Oct 21, 2026), via CGTN and AFP reporting: 1,466 confirmed cases Sep 29-Oct 19 (+10.4%), deaths +7.5% to 692; 9,637 confirmed / 4,646 deaths as of Oct 19; Kenya 9 cases in quarantine; WHO warning on Nigeria's prolonged symptom-to-confirmation interval
• AFP reporting (via IOL, Vanguard, ghanamma), Oct 22, 2026: WHO Africa chief Mohamed Janabi's online briefing ("more complex outbreak landscape"); Africa CDC DG Jean Kaseya's clarification that the Nigeria patient had not traveled to DRC; The Punch/NCDC emergency meeting details on the patient's travel
• Ghana Ministry of Health press release (via Starr FM), Oct 22, 2026: strengthened surveillance at points of entry, no cases in Ghana
• Africa CDC statements (via AFP/Malay Mail), Oct 20-21, 2026: "most geographically widespread Ebola outbreak in history," international appeal for funding and supplies
• WHO alert-and-response table, data as of Oct 18: 9,552 confirmed / 4,602 deaths / 2,550 recovered, CFR ~48%
• DRC National Institute for Biomedical Research / Ebola task force sitreps, Oct 2026
• Nigeria Centre for Disease Control statements, Oct 20-21, 2026